Skip to main content

Part of the book series: Current Molecular Medicine ((CMM,volume 1))

  • 93 Accesses

Abstract

Osteoporosis (thin bones) is a disease caused by loss of bone mass and microarchitectural deterioration of the skeleton, leading to enhanced bone fragility and increased risk for fractures with minimal or no trauma at all. Conventionally, the disease is diagnosed when the bone mineral density is 2.5 standard deviations below the young adult mean. A bone mineral density between 1 and 2.5 standard deviations below the young adult mean is termed “osteopenia.” Osteoporosis is the most common disease of the musculoskeletal system. Fifty-four percent of postmenopausal women in the United States have osteopenia and another 30% have osteoporosis. Up to 20% of patients with osteoporosis die after hip fractures and 40% can no longer live independently. Although not a rheumatic disorder, osteoporosis is of major interest to rheumatologists, as the arthritic processes that affect the cartilage surfaces and the synovial lining may also involve the subchondral bone and the joint capsule. Moreover, rheumatic diseases such as osteoarthritis, rheumatoid arthritis, systemic lupus erythematosus, and the spondyloarthropathies may involve not only skeletal tissues at juxtaarticular and subchondral sites but also produce generalized effects on bone remodeling that affect the entire skeleton.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Manolagas, S. C. and Jilka, R. L. (1995) Bone marrow, cytokines, and bone remodeling: emerging insights into the pathophysiology of osteoporosis. N. Engl. J. Med. 332, 305–311.

    Article  PubMed  CAS  Google Scholar 

  2. Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D., Abrams, J., et al. (1992) Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257, 88–91.

    Article  PubMed  CAS  Google Scholar 

  3. Hughes, D. E., Dai, A., Tiffee, J. C., Li, H. H., Mundy, G. R., and Boyce, B. F. (1996) Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-ß. Nature Med. 2, 1132–1136.

    Article  PubMed  CAS  Google Scholar 

  4. Girasole, G., Jilka, R. L., Passeri, G., Boswell, H. S., Boder, G., Williams, D. C., et al. (1992) 17ß-Estradiol inhibits Interleukin-6 production by murine bone marrow stromal cells and human osteoblasts in-vitro: a potential mechanism for the antiosteoporotic effects of estrogens. J. Clin. Invest. 89, 883–891.

    Article  PubMed  CAS  Google Scholar 

  5. Pottratz, S., Bellido, T., Mocharla, H., Crabb, D., and Manolagas, S. C. (1994) 17ß-Estradiol inhibits transcription from the human interleukin-6 promoter. J. Clin. Invest. 93, 944–950.

    Article  PubMed  CAS  Google Scholar 

  6. Bellido, T., Jilka, R. L., Boyce, B., Girasole, G., Broxmeyer, H., Dalrymple, S. A., et al. (1995) Regulation of interleukin-6, osteoclastogenesis and bone mass by androgens: the role of the androgen receptor. J. Clin. Invest. 95, 2886–2895.

    Article  PubMed  CAS  Google Scholar 

  7. Lin, S.-C., Yamate, T., Taguchi, Y., Borba, V. Z. C., Girasole, G., O’Brien, C. A., et al. (1997) Regulation of the gp80 and gp 130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow. J. Clin. Invest. 100, 1980–1990.

    Article  PubMed  CAS  Google Scholar 

  8. Poli, V., Balena, R., Fattori, E., Markatos, A., Yamamoto, A., Tanaka, H., et al. (1994) Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 13, 1189–1196.

    PubMed  CAS  Google Scholar 

  9. Jilka, R. L., Takahashi, K., Munshi, M., Williams, D. C., Roberson, P. K., Parfitt, A. M., et al. (1998) Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow: evidence for autonomy from factors released during bone resorption. J. Clin. Invest. 101, 1942–1950.

    Article  PubMed  CAS  Google Scholar 

  10. Weinstein, R. S., Jilka, R. L., Parfitt, A. M., and Manolagas, S. C. (1997) The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage. Endocrinology 138, 4013–4021.

    Article  PubMed  CAS  Google Scholar 

  11. Pacifici, R. (1998) Cytokines, estrogen, and postmenopausal osteoporosis: the second decade. Endocrinology 139, 2659–2661.

    Article  PubMed  CAS  Google Scholar 

  12. Sunyer, T., Lewis, J., Collin-Osdoby, P., and Osdoby, P. (1999) Estrogen’s bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells. J. Clin. Invest. 103, 1409–1418.

    Article  PubMed  CAS  Google Scholar 

  13. Manolagas, S. C., Weinstein, R. S., Bellido, T., and Bodenner, D. L. Opposite effects of estrogen on the life span of osteoblasts/osteocytes versus osteoclasts in vivo and in vitro: an explanation of the imbalance between formation and resorption in estrogen deficiency. J. Bone Miner. Res. (abstract), in press.

    Google Scholar 

  14. Jilka, R. L., Weinstein, R. S., Takahashi, K., Parfitt, A. M., and Manolagas, S. C. (1996) Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J. Clin. Invest. 97, 1732–1740.

    Article  PubMed  CAS  Google Scholar 

  15. Kajkenova, O., Lecka-Czernik, B., Gubrij, I., Hauser, S. P., Takahashi, K., Parfitt, A. M., et al. (1997) Increase adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia. J. Bone Miner. Res. 12, 1772–1779.

    Article  PubMed  CAS  Google Scholar 

  16. Lecka-Cznernik, B., Gubrij, I., Moerman, E. A., Kajkenova, O., Lipschitz, D. A., Manolagas, S. C., et al. (1999) Inhibition of Osf2/Cbfal expression and terminal osteoblast differentiation by PPAR-gamma 2. J. Cell. Biochem. 74, 357–371.

    Article  Google Scholar 

  17. Frost, H. M. (1960) In vivo osteocyte death. J. Bone Joint Surg. [Am.] 42, 138–143.

    Google Scholar 

  18. Weinstein, R. S., Jilka, R. L., Parfitt, A. M., and Manolagas, S. C. (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J. Clin. Invest. 102, 274–282.

    Article  PubMed  CAS  Google Scholar 

  19. Jilka, R. L., Weinstein, R. S., Bellido, T., Roberson, P., Parfitt, A. M., and Manolagas, S. C. (1999) Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J. Clin. Invest., 104, 439–446.

    Article  PubMed  CAS  Google Scholar 

  20. Lane, N. E., Sanchez, S., Modin, G. W., Genant, H. K., Pierini, E., and Arnaud, C. D. (1998) Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. J. Clin. Invest. 102, 1627–1633.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Manolagas, S.C. (2000). Osteoporosis. In: Tsokos, G.C. (eds) Principles of Molecular Rheumatology. Current Molecular Medicine, vol 1. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-018-6_26

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-018-6_26

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-182-0

  • Online ISBN: 978-1-59259-018-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics